These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 37163883)

  • 1. The course of insomnia symptoms during the acute treatment of major depressive disorder: A CAN-BIND-1 report.
    Dama M; Wu M; Tassone VK; Demchenko I; Frey BN; Milev RV; Ravindran AV; Parikh SV; Rotzinger S; Lou W; Lam RW; Kennedy SH; Bhat V;
    Psychiatry Res; 2023 Jul; 325():115222. PubMed ID: 37163883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved insomnia symptoms and sleep-related next-day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 mg and escitalopram treatment: a randomized controlled trial.
    Fava M; Asnis GM; Shrivastava RK; Lydiard B; Bastani B; Sheehan DV; Roth T
    J Clin Psychiatry; 2011 Jul; 72(7):914-28. PubMed ID: 21208597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ongoing or re-emerging subjective insomnia symptoms after full/partial remission or recovery of major depressive disorder mainly with the selective serotonin reuptake inhibitors and risk of relapse or recurrence: a 52-week follow-up study.
    Gulec M; Selvi Y; Boysan M; Aydin A; Besiroglu L; Agargun MY
    J Affect Disord; 2011 Nov; 134(1-3):257-65. PubMed ID: 21684011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of late life depressive symptoms on the trajectories of insomnia symptoms during antidepressant treatment.
    Gebara MA; Kasckow J; Smagula SF; DiNapoli EA; Karp JF; Lenze EJ; Mulsant BH; Reynolds CF
    J Psychiatr Res; 2018 Jan; 96():162-166. PubMed ID: 29069615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single i.v. ketamine augmentation of newly initiated escitalopram for major depression: results from a randomized, placebo-controlled 4-week study.
    Hu YD; Xiang YT; Fang JX; Zu S; Sha S; Shi H; Ungvari GS; Correll CU; Chiu HF; Xue Y; Tian TF; Wu AS; Ma X; Wang G
    Psychol Med; 2016 Feb; 46(3):623-35. PubMed ID: 26478208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does exercise improve self-reported sleep quality in non-remitted major depressive disorder?
    Rethorst CD; Sunderajan P; Greer TL; Grannemann BD; Nakonezny PA; Carmody TJ; Trivedi MH
    Psychol Med; 2013 Apr; 43(4):699-709. PubMed ID: 23171815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations.
    Troxel WM; Kupfer DJ; Reynolds CF; Frank E; Thase ME; Miewald JM; Buysse DJ
    J Clin Psychiatry; 2012 Apr; 73(4):478-85. PubMed ID: 22152403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia.
    Brooks S; Jacobs GE; de Boer P; Kent JM; Van Nueten L; van Amerongen G; Zuiker R; Kezic I; Luthringer R; van der Ark P; van Gerven JM; Drevets W
    J Psychopharmacol; 2019 Feb; 33(2):202-209. PubMed ID: 30644312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electroacupuncture for residual insomnia associated with major depressive disorder: a randomized controlled trial.
    Yeung WF; Chung KF; Tso KC; Zhang SP; Zhang ZJ; Ho LM
    Sleep; 2011 Jun; 34(6):807-15. PubMed ID: 21629370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder.
    Wang D; Li Z; Li L; Hao W
    Asia Pac Psychiatry; 2014 Jun; 6(2):152-60. PubMed ID: 23857869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Adjunctive Brexpiprazole on Sleep Disturbances in Patients With Major Depressive Disorder: An Open-Label, Flexible-Dose, Exploratory Study.
    Krystal AD; Mittoux A; Meisels P; Baker RA
    Prim Care Companion CNS Disord; 2016 Sep; 18(5):. PubMed ID: 27835722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptomatic and Functional Outcomes and Early Prediction of Response to Escitalopram Monotherapy and Sequential Adjunctive Aripiprazole Therapy in Patients With Major Depressive Disorder: A CAN-BIND-1 Report.
    Kennedy SH; Lam RW; Rotzinger S; Milev RV; Blier P; Downar J; Evans KR; Farzan F; Foster JA; Frey BN; Giacobbe P; Hall GB; Harkness KL; Hassel S; Ismail Z; Leri F; McInerney S; MacQueen GM; Minuzzi L; Müller DJ; Parikh SV; Placenza FM; Quilty LC; Ravindran AV; Sassi RB; Soares CN; Strother SC; Turecki G; Vaccarino AL; Vila-Rodriguez F; Yu J; Uher R;
    J Clin Psychiatry; 2019 Feb; 80(2):. PubMed ID: 30840787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Cognitive-Behavioral Therapy for Insomnia Combined With Antidepressant Pharmacotherapy in Patients With Comorbid Depression and Insomnia: A Randomized Controlled Trial.
    Manber R; Buysse DJ; Edinger J; Krystal A; Luther JF; Wisniewski SR; Trockel M; Kraemer HC; Thase ME
    J Clin Psychiatry; 2016 Oct; 77(10):e1316-e1323. PubMed ID: 27788313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are Patients with Childhood Onset of Insomnia and Depression More Difficult to Treat Than Are Those with Adult Onsets of These Disorders? A Report from the TRIAD Study.
    Edinger JD; Manber R; Buysse DJ; Krystal AD; Thase ME; Gehrman P; Fairholme CP; Luther J; Wisniewski S
    J Clin Sleep Med; 2017 Feb; 13(2):205-213. PubMed ID: 27784414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN; Thase ME; Clayton A; Guico-Pabia CJ; Focht K; Jiang Q; Kornstein SG; Ninan PT; Kane CP
    CNS Drugs; 2011 Mar; 25(3):227-38. PubMed ID: 21323394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline insomnia as a predictor of antidepressant efficacy to repeated intravenous ketamine for unipolar and bipolar depression: A preliminary study.
    Liu W; Zhou Y; Wang C; Zheng W; Zhan Y; Lan X; Zhang B; Li H; Chen L; Li M; Ning Y
    J Affect Disord; 2020 Jun; 271():1-8. PubMed ID: 32312692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study.
    Kadam RL; Sontakke SD; Tiple P; Motghare VM; Bajait CS; Kalikar MV
    Indian J Pharmacol; 2020; 52(2):79-85. PubMed ID: 32565594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of the sleep impact scale in patients with major depressive disorder and insomnia.
    Lasch K; Joish VN; Zhu Y; Rosa K; Qiu C; Crawford B
    Curr Med Res Opin; 2009 Jul; 25(7):1699-710. PubMed ID: 19505198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression.
    Fava M; Schaefer K; Huang H; Wilson A; Iosifescu DV; Mischoulon D; Wessel TC
    J Clin Psychiatry; 2011 Apr; 72(4):473-9. PubMed ID: 21208574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of escitalopram on sleep problems in patients with major depression or generalized anxiety disorder.
    Stein DJ; Lopez AG
    Adv Ther; 2011 Nov; 28(11):1021-37. PubMed ID: 22057726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.